Tags

Type your tag names separated by a space and hit enter

Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome.
Clin Gastroenterol Hepatol 2004; 2(7):576-84CG

Abstract

BACKGROUND & AIMS

The impact of education on irritable bowel syndrome (IBS) is not well known. This study evaluated the effect of a onetime group education program on patient-based outcomes in IBS.

METHODS

All adults referred by Mayo Clinic physicians to the Gastroenterology Division with a diagnosis of IBS between May 1997 and March 1998 were asked to participate. Questionnaires were administered at baseline and 6 months. Symptom resolution, change in pain severity, quality of life, Health-Promoting Lifestyle Profile score, overall patient satisfaction, and health care utilization were compared among those patients who attended the multidisciplinary class and those who did not.

RESULTS

Of the 506 patients approached, 403 (80%) agreed to participate. The clinical diagnosis was confirmed in 344 patients (85%) on chart review; 211 patients (61%) subsequently completed a follow-up questionnaire. Overall, 29% of class attendees who met Rome criteria for IBS at baseline no longer met Rome criteria at follow-up, compared with 7% of nonattendees. By multivariate analysis, class attendance predicted higher odds of not meeting Rome criteria at follow-up in individuals meeting Rome criteria at baseline (odds ratio, 7.91; 95% confidence interval, 0.97-64.41) than in nonattendees, but the opposite effect was seen with class attendance in those not meeting Rome criteria at baseline. This interaction between baseline Rome status and class attendance was significant (P < 0.05). Class attendance was associated with improvement in Health-Promoting Lifestyle Profile scores (P < 0.05) but not with change in pain, quality of life, satisfaction, or health care utilization.

CONCLUSIONS

A onetime, multidisciplinary class for patients with IBS was associated with improvement in symptoms and health-promoting lifestyle behavior.

Authors+Show Affiliations

Clinical Enteric Neuroscience Translational and Epidemiological Research, Mayo Clinic and Foundation, Rochester, MN 55905, USA. saito.yuri@mayo.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15224282

Citation

Saito, Yuri A., et al. "Effects of Multidisciplinary Education On Outcomes in Patients With Irritable Bowel Syndrome." Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, vol. 2, no. 7, 2004, pp. 576-84.
Saito YA, Prather CM, Van Dyke CT, et al. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2(7):576-84.
Saito, Y. A., Prather, C. M., Van Dyke, C. T., Fett, S., Zinsmeister, A. R., & Locke, G. R. (2004). Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 2(7), pp. 576-84.
Saito YA, et al. Effects of Multidisciplinary Education On Outcomes in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2004;2(7):576-84. PubMed PMID: 15224282.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. AU - Saito,Yuri A, AU - Prather,Charlene M, AU - Van Dyke,Carol T, AU - Fett,Sara, AU - Zinsmeister,Alan R, AU - Locke,G Richard,3rd PY - 2004/6/30/pubmed PY - 2004/9/24/medline PY - 2004/6/30/entrez SP - 576 EP - 84 JF - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association JO - Clin. Gastroenterol. Hepatol. VL - 2 IS - 7 N2 - BACKGROUND & AIMS: The impact of education on irritable bowel syndrome (IBS) is not well known. This study evaluated the effect of a onetime group education program on patient-based outcomes in IBS. METHODS: All adults referred by Mayo Clinic physicians to the Gastroenterology Division with a diagnosis of IBS between May 1997 and March 1998 were asked to participate. Questionnaires were administered at baseline and 6 months. Symptom resolution, change in pain severity, quality of life, Health-Promoting Lifestyle Profile score, overall patient satisfaction, and health care utilization were compared among those patients who attended the multidisciplinary class and those who did not. RESULTS: Of the 506 patients approached, 403 (80%) agreed to participate. The clinical diagnosis was confirmed in 344 patients (85%) on chart review; 211 patients (61%) subsequently completed a follow-up questionnaire. Overall, 29% of class attendees who met Rome criteria for IBS at baseline no longer met Rome criteria at follow-up, compared with 7% of nonattendees. By multivariate analysis, class attendance predicted higher odds of not meeting Rome criteria at follow-up in individuals meeting Rome criteria at baseline (odds ratio, 7.91; 95% confidence interval, 0.97-64.41) than in nonattendees, but the opposite effect was seen with class attendance in those not meeting Rome criteria at baseline. This interaction between baseline Rome status and class attendance was significant (P < 0.05). Class attendance was associated with improvement in Health-Promoting Lifestyle Profile scores (P < 0.05) but not with change in pain, quality of life, satisfaction, or health care utilization. CONCLUSIONS: A onetime, multidisciplinary class for patients with IBS was associated with improvement in symptoms and health-promoting lifestyle behavior. SN - 1542-3565 UR - https://www.unboundmedicine.com/medline/citation/15224282/Effects_of_multidisciplinary_education_on_outcomes_in_patients_with_irritable_bowel_syndrome_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1542356504002411 DB - PRIME DP - Unbound Medicine ER -